Skip to main content
Signal8

Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend

$JAGXPress releaseJun 25, 2026, 9:00 AM ETRead the release

Jaguar Health announced the mandatory conversion of its Series O Convertible Preferred Stock into common stock at a ratio of 3.209 to 1, effective June 25, 2026. The preferred stock was originally issued as a one-time special dividend in February to reward shareholders and protect against dilution during debt restructuring efforts. The company reiterated its focus on the global development program for crofelemer, a treatment for rare intestinal failure diseases. Management noted that the program continues to generate clinical proof-of-concept data and is part of ongoing business development discussions aimed at securing non-dilutive funding.

Key figures

Conversion ratio
3.209
Cash settlement price
2.68

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.